OmniBRx Biotechnologies

About:

OmniBRx Biotechnologies produces technologically-advanced bioreactors for the pharmaceutical industry.

Website: https://www.omnibrx.com

Twitter/X: omnibrx

Top Investors: Venture Center, SIDBI Venture Capital, Biotechnology Industry Research Assistance Council(BIRAC)

Description:

The Omnibrx Biotechnologies brought is an universal solution for the most efficient adherent cell culture processing with ultimate simplicity and scalability. The compact system, designed for quick implementation and ease-of-use, represents a new generation of rigid wall single-use bioreactors. Central to the CellBRx bioreactors technology is the use of a compact rotating dynamic-bed design, filled with custom disc shaped macro-carriers. This matrix discs are made of medical grade non-woven polyester microfibers (USP Class VI, ISO 10993 certifications) and available from 0.25L to 1000L working volume size.

Total Funding Amount:

300M INR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Ahmedabad, Gujarat, India

Founded Date:

2016-01-01

Contact Email:

info(AT)omnibrx.com

Founders:

Ravindra Patel

Number of Employees:

101-250

Last Funding Date:

2023-03-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai